[1] |
LI Shunle, LI Rong, TIAN Yaya, RAN Xiaoli, ZHAO Yanpei, XU Meng.
Association of serum KLF5 and actinin-4 levels with prognosis of TACE treatment for hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2024, 44(9): 1284-1289.
|
[2] |
ZHENG Hong, CHEN Xiaoxia, HAN Lizhou, CHEN Miao, HUANGFU Juan.
Decrease of lncRNA-RMRP expression inhibits proliferation and invasion of human lung cancer cell line A549
[J]. Basic & Clinical Medicine, 2024, 44(7): 974-978.
|
[3] |
LU Huiying, WANG Jianguo.
Downregulation of demethylase FTO inhibits proliferation of human liver cancer cell line HepG2
[J]. Basic & Clinical Medicine, 2024, 44(2): 185-191.
|
[4] |
Yimamaimaitijiang·ABRA, Pakhardin·BAIKERE, YI Chao, TONG Qing.
Clinical value of plasma hsa_circ_005230 in the diagnosis and prognosis evaluation of primary hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2023, 43(9): 1417-1422.
|
[5] |
LIN Yingxue, CUI Haipeng, WANG Aiguo, YAO Yinhui, ZHAO Juan.
Rapamycin alleviates hepatocellular carcinoma progressing in transgenic mice
[J]. Basic & Clinical Medicine, 2023, 43(8): 1241-1246.
|
[6] |
ZOU Jin, HE Xianglei, ZHANG Xin, CHEN Riping, ZHANG Yu, HU Shuaiyue, YING Shibo.
Expression of chemical modification enzymes PADs and PRMTs targeting protein arginine residues in human hepatocellular carcinoma cell lines
[J]. Basic & Clinical Medicine, 2023, 43(6): 898-903.
|
[7] |
JI Mengdie, YUAN Zan, BIAN Xiaocui, YANG Yurong, GUO Xin, WANG Qi, CHEN Yang.
Analysis of genomic copy number variations in human hepatocellular carcinoma cell lines HepG2 and Huh7
[J]. Basic & Clinical Medicine, 2023, 43(6): 960-966.
|
[8] |
LIU Aixia, ZHANG Hao, SUN Jie, YANG Lihua, ZHAO Xiaotao.
The role of GPS2 in regulating proliferation, migration and invasion of hepatocellular carcinoma cell line MHCC-97H
[J]. Basic & Clinical Medicine, 2023, 43(12): 1784-1791.
|
[9] |
CHA Na, HAO Dandan, LI Tianzhu.
Research progress of microRNAs suppressing tumorigenesis through Hippo signaling
[J]. Basic & Clinical Medicine, 2023, 43(12): 1871-1875.
|
[10] |
SU Yue, LIANG Linhui, HE Xianghuo.
Research progress on subcellular localization and function of long non-coding RNA
[J]. Basic & Clinical Medicine, 2023, 43(10): 1580-1584.
|
[11] |
HUANG Yisheng, YE Qiwen, WANG Jingfeng.
miR-203a-3p inhibits proliferation of human hepatocellular carcinoma cell lines
[J]. Basic & Clinical Medicine, 2023, 43(1): 87-94.
|
[12] |
QIU Libin, ZHANG Xincai, ZHAO Qian.
LncRNA DANCR reduces anoxia-induced rat myocardial cell line H9c2 injury by targeting miR-3646
[J]. Basic & Clinical Medicine, 2023, 43(1): 144-151.
|
[13] |
ZHAO Yu-shan, JI Meng-die, DONG Yu-cheng, GUO Xin, SONG Bo-yuan, CHEN Yang.
Epigenetic regulation mechanism of EZH2 gene in hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2022, 42(6): 864-870.
|
[14] |
XIE Li-hua, YANG Qi, LI Ya-qian, XIE Xin-yue, LEI Shi-juan, ZHOU Lin.
Transcription factor Kaiso down-regulates the expression of lncRNA MEG3 in human breast cancer cell lines
[J]. Basic & Clinical Medicine, 2022, 42(5): 758-762.
|
[15] |
HUANG Rong, ZHANG Jian, CHE Xu.
Effect of SLC4A10 expression on prognosis of patient with hepatocellular carcinoma
[J]. Basic & Clinical Medicine, 2022, 42(3): 461-466.
|